140 related articles for article (PubMed ID: 28065580)
1. Fatigue favors in vitro Th1 and Th17-like cell expansion and reduces corticoid sensitivity in MS patients.
Alvarenga-Filho H; Salles M; Hygino J; Ferreira TB; Sacramento PM; Monteiro C; Vasconcelos CC; Alvarenga RM; Bento CA
J Neuroimmunol; 2017 Feb; 303():81-89. PubMed ID: 28065580
[TBL] [Abstract][Full Text] [Related]
2. Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Ferreira TB; Barros PO; Teixeira B; Cassano T; Centurião N; Kasahara TM; Hygino J; Vasconcelos CC; Filho HA; Alvarenga R; Wing AC; Andrade RM; Andrade AF; Bento CA
Brain Behav Immun; 2014 Oct; 41():182-90. PubMed ID: 24882215
[TBL] [Abstract][Full Text] [Related]
3. Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Nischwitz S; Faber H; Sämann PG; Domingues HS; Krishnamoorthy G; Knop M; Müller-Sarnowski F; Yassouridis A; Weber F
Acta Neurol Scand; 2014 Jul; 130(1):46-52. PubMed ID: 24571587
[TBL] [Abstract][Full Text] [Related]
4. The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple Sclerosis.
Boyko A; Melnikov M; Zhetishev R; Pashenkov M
Neuroimmunomodulation; 2016; 23(4):217-223. PubMed ID: 27710965
[TBL] [Abstract][Full Text] [Related]
5. Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.
Peiravian F; Rajaian H; Samiei A; Gholijani N; Gharesi-Fard B; Mokaram P; Rahimi-Jaberi A; Kamali Sarvestani E
Iran J Immunol; 2016 Sep; 13(3):186-96. PubMed ID: 27671510
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
Karimi L; Eskandari N; Shaygannejad V; Zare N; Andalib A; Khanahmad H; Mirmosayyeb O
Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):416-425. PubMed ID: 33463108
[TBL] [Abstract][Full Text] [Related]
7. Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.
Ferreira TB; Hygino J; Barros PO; Teixeira B; Kasahara TM; Linhares UC; Lopes LM; Vasconcelos CC; Alvarenga R; Wing AC; Andrade RM; Andrade AF; Bento CA
Immunology; 2014 Dec; 143(4):560-8. PubMed ID: 24919524
[TBL] [Abstract][Full Text] [Related]
8. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
9. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
Babaloo Z; Aliparasti MR; Babaiea F; Almasi S; Baradaran B; Farhoudi M
Immunol Lett; 2015 Apr; 164(2):76-80. PubMed ID: 25625963
[TBL] [Abstract][Full Text] [Related]
10. Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39
do Sacramento PM; Sales M; Kasahara TM; Monteiro C; Oyamada H; Dias ASO; Lopes L; Castro CT; Rossi ÁD; Milioni LM; Agrawal A; Alvarenga R; Vasconcelos CC; Bento CAM
Cell Mol Life Sci; 2022 May; 79(6):298. PubMed ID: 35585332
[TBL] [Abstract][Full Text] [Related]
11. Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients.
Chatzantoni K; Papathanassopoulos P; Gourzoulidou E; Mouzaki A
J Autoimmun; 2004 Sep; 23(2):169-77. PubMed ID: 15324935
[TBL] [Abstract][Full Text] [Related]
12. Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.
Gross CC; Schulte-Mecklenbeck A; Hanning U; Posevitz-Fejfár A; Korsukewitz C; Schwab N; Meuth SG; Wiendl H; Klotz L
Mult Scler; 2017 Jun; 23(7):1025-1030. PubMed ID: 27481205
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines.
Ibrahim JN; Jounblat R; Delwail A; Abou-Ghoch J; Salem N; Chouery E; Megarbane A; Medlej-Hashim M; Lecron JC
Cytokine; 2014 Oct; 69(2):248-54. PubMed ID: 25025954
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Wing AC; Hygino J; Ferreira TB; Kasahara TM; Barros PO; Sacramento PM; Andrade RM; Camargo S; Rueda F; Alves-Leon SV; Vasconcelos CC; Alvarenga R; Bento CA
Immunology; 2016 Feb; 147(2):212-20. PubMed ID: 26781085
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Zhang X; Tao Y; Wang J; Garcia-Mata R; Markovic-Plese S
Eur J Immunol; 2013 Jan; 43(1):281-9. PubMed ID: 23076801
[TBL] [Abstract][Full Text] [Related]
18. Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
Teixeira B; Bittencourt VC; Ferreira TB; Kasahara TM; Barros PO; Alvarenga R; Hygino J; Andrade RM; Andrade AF; Bento CA
Clin Immunol; 2013 Aug; 148(2):209-18. PubMed ID: 23778260
[TBL] [Abstract][Full Text] [Related]
19. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
[TBL] [Abstract][Full Text] [Related]
20. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR
Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
